Navigation Links
New 'bubble' targets only cancer cells
Date:2/19/2009

For millions of Americans with cancer, the side effects of chemotherapy and other treatment drugs can be devastating. But new drug-delivery research based on nano- and microtechnology from Tel Aviv University might provide much-needed relief, as well as more effective cancer treatment.

New drug delivery technology developed by Prof. Rimona Margalit of Tel Aviv University's Department of Biochemistry allows drugs to target cancer cells specifically, leaving surrounding healthy cells intact and reducing the painful side effects of chemotherapy. The science utilizes tiny bubbles, visible only through powerful microscopes, that contain payloads of therapeutic drugs.

"This development is on the leading edge of the new frontier of drug delivery and cancer treatment," says Prof. Margalit. "Bubble technology can also be applied to other medical conditions, including diabetes, osteoarthritis, wounds, and infectious diseases. In twenty years, it could be widespread."

Target: Cancer

Currently, cancer drugs travel throughout the body delivering powerful medication to all the cells they encounter, both healthy and cancerous. When healthy cells are damaged by unnecessary medication, a patient can experience unpleasant side effects ranging from hair loss to nausea. More worrying are further health risks due to the damage that the medication does to the patient's immune system.

Called "drug carriers" recent reports of Prof. Margalit's new technology applied in both cancer and osteoarthritis therapies were published in Nature Nanotechnology, and in the Journal of Controlled Release (2008). The technology allows cancer treatment medication to be placed inside tiny bubbles so small that millions fit along a single inch. The surface of the bubbles contains an agent that allows them distinguish cancer cells from healthy ones. When the bubbles "recognize" a cancer cell, they deliver the medication they're carrying to that cell.

The positive results are twofold: More of the drug gets directly to the cancer cells, enhancing the effectiveness of the treatment, and healthy cells continue to function normally, protected against the painful side-effects of the medication.

Economics, Not Science, Is Researchers' Next Challenge

Prof. Margalit's drug carrier technology has already performed well in animal model studies. The next step is to apply the technology to humans. "Economics is the hold-up, not the science," explains Prof. Margalit, who is in the process of finding a pharmaceutical company to invest in the research.

Although the technology is still a decade or more from clinical trials, this promising discovery offers new hope in oncology.


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert  

Related medicine news :

1. Micro-Bubble Echo Contrast Procedures Continue to Rebound in October 2008
2. VIDEO from Medialink and Philips: Microbubbles Developed to Administer Medications That Fight Cancer and Reduce Side Effects
3. Cancer cells spread by releasing bubbles, according to an MUHC study
4. Wisconsin First State in Nation to Screen Newborns for Bubble Boy Disease
5. OHSU vaccine research targets HIV in the slower, early stage of infection
6. Nanoparticle smart bomb targets drug delivery to cancer cells
7. NHHF Scholarship Program Targets Growing Demand for Diversity Among Health Care Professionals
8. New Institute Targets Brain Tumor Survival
9. New institute targets brain tumor removal
10. Engineered virus targets and kills apparent cancer stem cells in neuroblastoma
11. New Vitamin Targets Health Needs of Firefighters
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New 'bubble' targets only cancer cells
(Date:1/21/2017)... ... January 21, 2017 , ... Caronlab Australia, an Australian company ... ECRM Trade Show in Hilton Head, SC, where it benefited from outstanding meetings with ... of its beauty and wellness products. At this trade show, the company had the ...
(Date:1/21/2017)... CA (PRWEB) , ... January 21, 2017 , ... ... Director of Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its ... for alumni, family, friends, and community. “Coming Home 2017” will be held ...
(Date:1/20/2017)... ... 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 Lift. Built for ... mounted on wheels, it can be wheeled out of the way and stored when not ... deck. "We have transformed the feedback from customers into specific enhancements and created a new ...
(Date:1/20/2017)... ... 2017 , ... Bionic Sports Nutrition LLC, an American company devoted to developing ... successful January ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition ... provide its products to all clients at reasonable prices. At the ECRM trade show, ...
(Date:1/20/2017)... ... ... "TransFlare 4K Mystique comes with 44 colorful mysterious transitions that are fully ... - CEO of Pixel Film Studios. , TransFlare 4K Mystique contains 44 lens ... and light leak transitions have a very high-dynamic range for super smooth falloff. Simply ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017  Faruqi & Faruqi, LLP, ... Inc. ("KemPharm" or the "Company") (NASDAQ: KMPH ) ... Company and certain officers and directors and underwriters of the ... seek the role of lead plaintiff. The lawsuit ... District Court for Johnson County on ...
(Date:1/20/2017)... Research and Markets has announced the addition of ... OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis and Forecast ... ... Sales Volume, Company Analysis and Forecast to 2022 provides a ... The growing prevalence of hearing impairment coupled with an ...
(Date:1/20/2017)... -- Stock-Callers.com today evaluates the following Drug Manufacturers ... Nordisk A/S (NYSE: NVO ), Sucampo Pharmaceuticals Inc. ... (NASDAQ: PTX ). These stocks belong to the ... 2017, finishing near its session lows. As per a NASDAQ ... shares of health care companies in the S&P 500 also ...
Breaking Medicine Technology: